Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
J Hepatol ; 40(3): 409-16, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15123354

ABSTRACT

BACKGROUND/AIMS: Tetrathiomolybdate (TTM) is a potent copper-chelating agent that has been shown to be effective in Wilson disease patients with neurological symptoms. Here, we investigate the potential use of TTM in treating the acute hepatic copper toxicosis in Long-Evans Cinnamon (LEC) rats, an authentic model for Wilson disease. METHODS: After the onset of acute hepatitis, LEC rats were treated once with 10 mg TTM/kg. After 1 and 4 days, parameters of liver toxicity and the subcellular distribution and binding of copper and iron were studied. RESULTS: In 11 out of 12 rats TTM rapidly improved acute hepatitis. Hepatic copper decreased through removal from cytosolic metallothionein and lysosomal metallothionein polymers. The remaining lysosomal copper forms a metallothionein-copper-TTM complex. In an almost moribund rat, however, TTM caused severe hepatotoxicity with fatal outcome. CONCLUSIONS: TTM is effective in treating acute hepatitis in LEC rats when applied before the animals become moribund. TTM appears to act by removing the presumable reactive copper associated to lysosomal metallothionein polymers. The remaining lysosomal copper seems to be inactivated by forming a complex with TTM. Moreover, TTM removes copper from cytosolic copper-containing metallothionein. As a consequence, metallothionein is degraded and the uptake of copper-metallothionein into the lysosomes and the formation of the metallothionein polymer associated copper is reduced.


Subject(s)
Chelating Agents/pharmacology , Copper/antagonists & inhibitors , Hepatitis, Animal/metabolism , Hepatitis, Animal/pathology , Hepatolenticular Degeneration/complications , Molybdenum/pharmacology , Acute Disease , Animals , Copper/metabolism , Disease Models, Animal , Female , Hepatitis, Animal/etiology , Liver/drug effects , Liver/metabolism , Liver/pathology , Microscopy, Electron , Rats , Rats, Inbred LEC , Rats, Long-Evans , Subcellular Fractions/metabolism , Tissue Distribution
2.
Arch Toxicol ; 77(10): 568-75, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14574444

ABSTRACT

The Long-Evans cinnamon (LEC) rat, an authentic model for Wilson disease, is characterized by a mutation in the Atp7b gene leading to a defective copper excretion and, as a consequence, to an accumulation of the metal in the liver and copper-associated hepatotoxicity. In the present communication expression profiles of genes in the liver from wild-type Long-Evans agouti (LEA) and LEC rats at different stages of copper accumulation and liver disease were investigated. Disease states were defined according to serum aspartate aminotransferase activity and bilirubin levels in serum and from histopathology of the liver. Gene expression was determined with the Affymetrix RTU34 oligonucleotide array covering 1031 genes. Compared to the LEA rat, the nondiseased LEC rat with already increased hepatic copper level showed an enhanced expression of genes, particularly related to oxidative stress and DNA damage. During the progression of the liver disease, in particular genes related to oxidative stress, DNA damage, apoptosis and inflammation with acute-phase reaction were upregulated.


Subject(s)
Gene Expression Profiling , Hepatitis, Animal/metabolism , Liver/metabolism , Acute-Phase Reaction/genetics , Animals , Apoptosis/genetics , Copper/metabolism , DNA Damage/genetics , Female , Hepatitis, Animal/etiology , Hepatitis, Animal/pathology , Liver/pathology , Oligonucleotide Array Sequence Analysis , Rats , Rats, Inbred LEC , Rats, Long-Evans , Up-Regulation
SELECTION OF CITATIONS
SEARCH DETAIL
...